View the BRIGAMAKS registration information details.
Back to drug list
ItemsDrug Registration information
ID882
No882
Brand NameBRIGAMAKS
IngredientsBRIGATINIB 90 MG
Dosage FormFILM COATED TABLET
Primary PackagingBOTTLE
Storage
Shelf Life3 YEARS
Pack SizeBOX OF 30'S/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsFOR THE TREATMENT OF PATIENTS WITH ANAPLASTIC LYMPHOMA KINASE-POSITIVE METASTATIC NON - SMALL CELL LUNG CANCER WHOSE DISEASE HAS PROGRESSED ON OR ARE TOLERANT TO CRIZOTINIB
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionWHITE, BICONVEX FILM COATED TABLET
Note
License OwnerFACTORY NO.2
ManufacturerFACTORY NO. 2
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No11 L 1240/24
FDD Registration Date19/11/2024
Expiry Date18/11/2029
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA